Beit Jala Pharmaceutical Company (PEX:BJP)
Palestine
· Delayed Price · Currency is JOD 3.500
+0.120 (3.55%)
At close: Dec 2, 2025
PEX:BJP Ratios and Metrics
Market cap in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 1, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 25 | 20 | 20 | 20 | 19 | 18 | Upgrade
|
| Market Cap Growth | - | - | -1.75% | 5.56% | 5.88% | 5.81% | Upgrade
|
| Enterprise Value | 23 | 20 | 19 | 21 | 21 | 20 | Upgrade
|
| Last Close Price | 3.50 | 2.68 | 2.58 | 2.54 | 2.40 | 2.18 | Upgrade
|
| PE Ratio | 8.96 | 11.16 | 10.67 | 10.07 | 21.70 | 23.95 | Upgrade
|
| PS Ratio | 2.03 | 2.03 | 2.04 | 1.85 | 1.94 | 2.05 | Upgrade
|
| PB Ratio | 1.34 | 1.27 | 1.34 | 1.51 | 1.52 | 1.49 | Upgrade
|
| P/TBV Ratio | 1.34 | 1.27 | 1.34 | 1.51 | 1.52 | 1.49 | Upgrade
|
| P/FCF Ratio | 14.55 | 89.61 | 29.24 | 7.09 | 70.56 | - | Upgrade
|
| P/OCF Ratio | 4.96 | 21.66 | 10.13 | 6.20 | 17.36 | 9.29 | Upgrade
|
| EV/Sales Ratio | 1.88 | 2.10 | 2.00 | 1.91 | 2.16 | 2.26 | Upgrade
|
| EV/EBITDA Ratio | 3.98 | 7.78 | 5.89 | 6.22 | 9.94 | 9.90 | Upgrade
|
| EV/EBIT Ratio | 6.97 | 10.53 | 8.90 | 8.73 | 19.01 | 18.60 | Upgrade
|
| EV/FCF Ratio | 13.48 | 92.58 | 28.65 | 7.30 | 78.56 | - | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.09 | 0.06 | 0.14 | 0.27 | 0.18 | Upgrade
|
| Debt / EBITDA Ratio | 0.03 | 0.56 | 0.29 | 0.55 | 1.57 | 1.11 | Upgrade
|
| Debt / FCF Ratio | 0.09 | 6.64 | 1.39 | 0.65 | 12.41 | - | Upgrade
|
| Asset Turnover | 0.59 | 0.51 | 0.52 | 0.56 | 0.53 | 0.52 | Upgrade
|
| Inventory Turnover | 2.04 | 1.94 | 2.02 | 2.26 | 2.64 | 2.94 | Upgrade
|
| Quick Ratio | 4.03 | 2.07 | 2.49 | 1.60 | 1.18 | 1.77 | Upgrade
|
| Current Ratio | 6.42 | 3.52 | 4.45 | 2.44 | 1.94 | 2.97 | Upgrade
|
| Return on Equity (ROE) | 16.50% | 11.70% | 13.23% | 15.45% | 7.13% | 6.18% | Upgrade
|
| Return on Assets (ROA) | 9.91% | 6.30% | 7.22% | 7.60% | 3.77% | 3.92% | Upgrade
|
| Return on Capital (ROIC) | 11.75% | 7.42% | 8.83% | 9.56% | 4.62% | 4.66% | Upgrade
|
| Return on Capital Employed (ROCE) | 16.30% | 11.40% | 13.30% | 15.70% | 7.60% | 7.20% | Upgrade
|
| Earnings Yield | 11.09% | 8.96% | 9.37% | 9.93% | 4.61% | 4.18% | Upgrade
|
| FCF Yield | 6.87% | 1.12% | 3.42% | 14.11% | 1.42% | -0.54% | Upgrade
|
| Dividend Yield | 3.43% | 4.48% | 3.87% | 3.94% | 4.16% | 4.58% | Upgrade
|
| Payout Ratio | 30.91% | 39.86% | 38.10% | 35.33% | 80.36% | 140.88% | Upgrade
|
| Buyback Yield / Dilution | 0.63% | - | - | - | - | - | Upgrade
|
| Total Shareholder Return | 4.06% | 4.48% | 3.87% | 3.94% | 4.16% | 4.58% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.